RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 Novel Anticoagulants in Vascular Neurology Practice
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 1
SP 30
OP 31
DO 10.1177/155989771301015
UL http://mdc.sagepub.com/content/13/1/30.abstract
AB This article gives an overview of warfarin in stroke prevention compared with the new oral anticoagulants (NOACs). While warfarin has been widely used in stroke prevention, it has less desirable attributes such as difficulties in achieving the correct therapeutic dose, interpatient variability, medication compliance, food and drug interactions, and variability amongst generic formulations. Also discussed are the benefits of warfarin versus NOACs in secondary prevention, and a brief summary of patient considerations with NOACs based on clinical trial data.